Approval · Notice of Compliance 3422 · 2003
OXYCONTIN: Notice of Compliance 3422
Issued September 25, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3422
- Date
- September 25, 2003
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised indication: to clarify indication to specify relief of moderate to severe pain requiring the continuous use of an opioid analgesic preparation for several days or more
- Therapeutic class
- Opioid analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OXYCONTIN | Not yet assigned | — |